These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

93 related articles for article (PubMed ID: 12516425)

  • 21. The optimization of continuous ambulatory peritoneal dialysis.
    Oreopoulos DG
    Kidney Int; 1999 Mar; 55(3):1131-49. PubMed ID: 10027956
    [No Abstract]   [Full Text] [Related]  

  • 22. [Comparison of peritoneal transport of solutes and water during CAPD with glucose or amino acids solutions. Preliminary report].
    Olszowska A; Waniewski J; Weryński A; Marciniak M; Wańkowicz Z
    Pol Merkur Lekarski; 2002 Nov; 13(77):389-92. PubMed ID: 12621755
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Dialysis dose and nutrition in Japanese peritoneal dialysis patients.
    Ishizaki M; Yamashita AC; Kawanishi H; Nakamoto M; Hamada H
    Adv Perit Dial; 2004; 20():141-3. PubMed ID: 15384815
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Mesenchymal conversion of mesothelial cells as a mechanism responsible for high solute transport rate in peritoneal dialysis: role of vascular endothelial growth factor.
    Aroeira LS; Aguilera A; Selgas R; Ramírez-Huesca M; Pérez-Lozano ML; Cirugeda A; Bajo MA; del Peso G; Sánchez-Tomero JA; Jiménez-Heffernan JA; López-Cabrera M
    Am J Kidney Dis; 2005 Nov; 46(5):938-48. PubMed ID: 16253736
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Longitudinal changes of peritoneal function calculated by personal dialysis capacity in a patient after long-term continuous ambulatory peritoneal dialysis.
    Nakamoto H; Takane H; Sugahara S; Kanno Y; Okada H; Yamamoto T; Suzuki H
    Adv Perit Dial; 2003; 19():97-102. PubMed ID: 14763042
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Chronic peritoneal dialysis in diabetic patients with end-stage renal failure.
    Finkelstein FO; Kliger AS; Bastl C; Yap P; Goffinet J
    Proc Clin Dial Transplant Forum; 1975 Nov; 5():142-5. PubMed ID: 785454
    [No Abstract]   [Full Text] [Related]  

  • 27. Evaluating peritoneal fluid transport in continuous peritoneal dialysis patients: a practical approach.
    Zhe XW; Tian XK; Shan YS; Cheng L; Wang T
    Nephron Clin Pract; 2007; 107(4):c123-7. PubMed ID: 17957122
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Computation of the dose of continuous peritoneal dialysis required for adequate peritoneal urea clearance without taking into account peritoneal transport indices.
    Tzamaloukas AH; Onime A; Raj DS; Murata GH; VanderJagt DJ; Servilla KS
    Adv Perit Dial; 2007; 23():122-6. PubMed ID: 17886617
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Peritoneal dialysis in the treatment of chronic renal failure].
    Kazimirov VG; Butrin SV; Bekov RR; Sapozhnikov AD; Kharitonov BI; Smoliakov AM; Detinenko IN
    Urologiia; 2004; (5):58-62. PubMed ID: 15560166
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The peritoneal equilibration test.
    Peritoneal Dialysis Special Interest Group
    Nephrol Nurs J; 2005; 32(4):452-3. PubMed ID: 16180789
    [No Abstract]   [Full Text] [Related]  

  • 31. 3,4-Dideoxyglucosone-3-ene as a mediator of peritoneal demesothelization.
    Santamaría B; Ucero AC; Reyero A; Selgas R; Ruiz-Ortega M; Catalán M; Egido J; Ortiz A
    Nephrol Dial Transplant; 2008 Oct; 23(10):3307-15. PubMed ID: 18524790
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Peritoneal elimination of homocysteine moieties in continuous ambulatory peritoneal dialysis.
    De Vecchi AF; Catena FB; Accinni R; Patrosso C
    Kidney Int; 1999 Oct; 56(4):1604-5. PubMed ID: 10610417
    [No Abstract]   [Full Text] [Related]  

  • 33. The relationship between peritoneal transport characteristics and messenger RNA expression of aquaporin in the peritoneal dialysis effluent of CAPD patients.
    Szeto CC; Lai KB; Chow KM; Szeto CY; Li PK
    J Nephrol; 2005; 18(2):197-203. PubMed ID: 15931648
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Two years on continuous ambulatory peritoneal dialysis--does it change peritoneal transport?
    Kaczmarek EE; Grzegorzewska AE
    Adv Perit Dial; 2004; 20():2-7. PubMed ID: 15384785
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Difficulty in improving malnutrition and low-grade inflammation in diabetic patients on peritoneal dialysis.
    Park SW; Seo JJ; Bae HS; Kim JY; Kim CD; Park SH; Kim YL
    Ther Apher Dial; 2008 Dec; 12(6):475-83. PubMed ID: 19140846
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [The effect of drugs on peritoneal dialysis clearance].
    Djukanović Lj; Ikonomovski J; Milovanović D
    Srp Arh Celok Lek; 1984 Jan; 112(1):115-26. PubMed ID: 6505849
    [No Abstract]   [Full Text] [Related]  

  • 37. Impact of dialysis duration and glucose absorption on nutritional indices in stable continuous ambulatory peritoneal dialysis patients.
    Pajek J; Gucek A; Kveder R; Bucar-Pajek M; Kaplan-Pavlovcic S; Bren AF
    J Ren Nutr; 2008 Nov; 18(6):503-8. PubMed ID: 18940653
    [TBL] [Abstract][Full Text] [Related]  

  • 38. PD: a biological membrane and a non-biological fluid.
    Jörres A
    Contrib Nephrol; 2003; (140):1-9. PubMed ID: 12800338
    [No Abstract]   [Full Text] [Related]  

  • 39. Compositional and oxidative analysis in the saliva and serum of predialysis chronic kidney disease patients and end-stage renal failure patients on peritoneal dialysis.
    Bibi G; Green Y; Nagler RM
    Ther Apher Dial; 2008 Apr; 12(2):164-70. PubMed ID: 18387167
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Evaluation of peritoneal transport properties at onset of peritoneal dialysis and longitudinal follow-up.
    Clerbaux G; Francart J; Wallemacq P; Robert A; Goffin E
    Nephrol Dial Transplant; 2006 Apr; 21(4):1032-9. PubMed ID: 16364990
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.